Immunology

Roughly 300 million people around the world suffer from immune-mediated diseases, including psoriatic disease, inflammatory bowel disease, and a wide variety of rare diseases. Of those, only a fraction receive advanced therapies that effectively treat their conditions.

Driven by this unmet need, and guided by actionable science, we work each day to redefine the standard of care by delivering transformational and accessible therapies. At Johnson & Johnson Innovative Medicine, our approach blends our expertise in science and commercial strategies.

Fueled by our advancements in pathway science and reinforced by our extensive market research and meaningful connections with patient communities, our teams are developing novel classes of therapies, potentially creating new treatment paradigms with increased access for patients.

We wake up each day inspired to achieve our mission of remission.